Countermeasures to the supply chain disruptions in medical and pharmaceutical industries
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 170653
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$93,035.66Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Fuminori ToyasakiResearch Location
CanadaLead Research Institution
York UniversityResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Other secondary impacts
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The intended research project focuses on the supply chain disruptions that medical/pharmaceutical industries are currently facing in the Novel Coronavirus Outbreak, due to the suppliers' strategic hoarding and consumers' panic buying behavior under psychological and behavioral uncertainties. Specifically, this proposed research project explores: factors that delay the resilience of medical/pharmaceutical industries' supply chain disruptions caused by the Novel Coronavirus Outbreak; and the feasibility of two countermeasures to the virus outbreak that we propose: (1) establishing a collaborative stock sharing/transshipment system; and (2) making an incentive contract with a potential second source that can produce highly customized medical/pharmaceutical items (e.g., protective clothing for or a new drug for novel viruses).